National Wealth Management Group’s Evoke Pharma EVOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-80,130
Closed -$398K 260
2025
Q3
$398K Buy
+80,130
New +$398K 0.15% 154

National Wealth Management Group's EVOK Position: Q4 2025 in Review

National Wealth Management Group sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 80,130 shares — an estimated $398K sold.

National Wealth Management Group first reported a position in EVOK in Q3 2025 and held it in 1 quarter. The position peaked at $398K in Q3 2025. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.

  • National Wealth Management Group reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
  • National Wealth Management Group sold 80,130 Evoke Pharma shares in Q4 2025, an estimated $398K.
  • National Wealth Management Group first reported a position in Evoke Pharma in Q3 2025 and held it in 1 quarter.
  • National Wealth Management Group's Evoke Pharma position peaked at $398K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.

Based on National Wealth Management Group's 13F filing for Q4 2025, filed 12 Jan 2026.